Zobrazeno 1 - 10
of 46
pro vyhledávání: '"Thomas A Ollila"'
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
Classic Hodgkin lymphoma (cHL) treatment paradigms are undergoing a shift with the integration of immune checkpoint inhibitors (ICIs) into both first-line and relapsed/refractory (R/R) regimens. In first-line therapy, the synergy between ICIs and che
Externí odkaz:
https://doaj.org/article/6c598591104d46f69fa2b21167addff1
Autor:
Kevin A. David, Suchitra Sundaram, Seo‐Hyun Kim, Ryan Vaca, Yong Lin, Samuel Singer, Mary‐Kate Malecek, Jordan Carter, Adam Zayac, Myung Sun Kim, Nishitha Reddy, Douglas Ney, Alma Habib, Christopher Strouse, Jerome Graber, Veronika Bachanova, Sidra Salman, Jean Alyxa Vendiola, Nasheed Hossain, Mazie Tsang, Ajay Major, David A. Bond, Prashasti Agrawal, Angel Mier‐Hicks, Pallawi Torka, Priya Rajakumar, Parameswaran Venugopal, Stephanie Berg, Michael Glantz, Samuel A. Goldlust, Matthew Folstad, Pallavi Kumar, Thomas A. Ollila, Johnny Cai, Stephen Spurgeon, Alex Sieg, Joseph Cleveland, Julie Chang, Narendranath Epperla, Reem Karmali, Seema Naik, Peter Martin, Sonali M. Smith, James Rubenstein, Brad Kahl, Andrew M. Evens
Publikováno v:
American Journal of Hematology. 98:900-912
Autor:
Prashasti Agrawal, Kevin A. David, Zhengming Chen, Suchitra Sundaram, Seo-Hyun Kim, Ryan Vaca, Yong Lin, Samuel Singer, Mary-Kate Malecek, Jordan Carter, Adam Zayac, Myung Sun Kim, Nishitha Reddy, Douglas Ney, Alma Habib, Christopher Strouse, Jerome Graber, Veronika Bachanova, Sidra Salman, Jean A. Vendiola, Nasheed Hossain, Mazie Tsang, Ajay Major, Maher K. Gandhi, Colm Keane, David A. Bond, Matthew Folstad, Julie Chang, Angel Mier-Hicks, Pallawi Torka, Priya Rajakumar, Parameswaran Venugopal, Stephanie Berg, Michael Glantz, Samuel A. Goldlust, Rahul Matnani, Pallavi Kumar, Thomas A. Ollila, Johnny Cai, Stephen E. Spurgeon, Alex G. Sieg, Joseph Cleveland, Narendranath Epperla, Reem Karmali, Seema Naik, Sonali M. Smith, James L. Rubenstein, Brad S. Kahl, Amy Chadburn, Andrew M. Evens, Peter Martin
Publikováno v:
Leukemia & Lymphoma. :1-9
Autor:
Thomas A. Ollila, Rebecca H. Masel, John L. Reagan, Shaolei Lu, Ralph D. Rogers, Kimberly J. Paiva, Rashida Taher, Ella Burguera‐Couce, Adam S. Zayac, Inna Yakirevich, Rabin Niroula, Peter Barth, Adam J. Olszewski
Publikováno v:
Cancer. 128:3319-3329
Patients with hematologic malignancies have impaired humoral immunity secondary to their malignancy and its treatment, placing them at risk of severe coronavirus disease-19 (COVID-19) infection and reduced response to vaccination.The authors retrospe
Autor:
Reem Karmali, Narendranath Epperla, Geoffrey Shouse, Jason T. Romancik, Tamara K. Moyo, Vaishalee P. Kenkre, Thomas A. Ollila, Lindsey A. Fitzgerald, Brian T. Hess, Andrew M. Evens, Ishan Roy, Joanna Zurko, Sayan Mullick Chowdhury, Kaitlin Annunzio, Robert Ferdman, Rahul Bhansali, Elyse I. Harris, McKenzie Sorrell, Jieqi Liu, Imran A. Nizamuddin, Shuo Ma, Jonathan Moreira, Jane N. Winter, Barbara Pro, Deborah M. Stephens, Alexey V Danilov, Nirav N. Shah, Jonathon B. Cohen, Stefan K. Barta, Pallawi Torka, Leo I. Gordon
Publikováno v:
Blood. 140:10955-10957
Autor:
Joanna Zurko, Geoffrey Shouse, Pallawi Torka, Tamara K. Moyo, Jason T. Romancik, Imran A. Nizamuddin, Kaitlin Annunzio, Jieqi Liu, Stefan K. Barta, Robert Ferdman, Rahul Bhansali, Jonathon B. Cohen, Sayan Mullick Chowdhury, Nirav N. Shah, Elyse I. Harris, Vaishalee P. Kenkre, McKenzie Sorrell, Brian T. Hess, Deborah M. Stephens, Lindsey A. Fitzgerald, Thomas A. Ollila, Ishan Roy, Shuo Ma, Jane N. Winter, Barbara Pro, Jonathan Moreira, Leo I. Gordon, Alexey V Danilov, Andrew M. Evens, Narendranath Epperla, Reem Karmali
Publikováno v:
Blood. 140:375-377
Autor:
Ishan Roy, Narendranath Epperla, Geoffrey Shouse, Jason T. Romancik, Tamara K. Moyo, Vaishalee P. Kenkre, Thomas A. Ollila, Lindsey A. Fitzgerald, Brian T. Hess, Andrew M. Evens, Joanna Zurko, Sayan Mullick Chowdhury, Kaitlin Annunzio, Robert Ferdman, Rahul S. Bhansali, Elyse I. Harris, McKenzie Sorrell, Jieqi Liu, Imran A. Nizamuddin, Jonathan Moreira, Shuo Ma, Jane N. Winter, Barbara Pro, Deborah M. Stephens, Alexey V Danilov, Nirav N. Shah, Jonathon B. Cohen, Stefan K. Barta, Pallawi Torka, Leo I. Gordon, Reem Karmali
Publikováno v:
Blood. 140:2416-2418
Autor:
Benjamin Gallo Marin, Thomas A. Ollila, Allison Robbins, Blake E. Brooks, Elnaz F. Firoz, Cathy M. Massoud
Publikováno v:
American Journal of Hematology. 98:697-699
Autor:
Andrew R. Hsu, Pamela C Egan, Diana O. Treaba, Max Petersen, James N. Butera, Rabin Niroula, Adam J. Olszewski, Anna Chorzalska, Patrycja M. Dubielecka, John L. Reagan, Thomas A Ollila, Adam Zayac, John Vatkevich, Jordan Robison, Ilyas Sahin, Chelsea D. Mullins, Habibe Kurt, Allison P. Jacob
Publikováno v:
Blood Advances
Key Points The NGS-MRD assay detected clonotypic DNA in 100% of CSF samples from patients who had lymphoma with parenchymal CNS involvement.Clonotypic DNA in CSF was present in 36% of newly diagnosed aggressive lymphomas and was associated with a 29%
Autor:
Joanna C Zurko, Imran Nizamuddin, Narendranath Epperla, Kevin A David, Jonathon B. Cohen, Tamara Moyo, Thomas A Ollila, Brian T. Hess, Ishan Roy, Robert Ferdman, Jieqi Liu, Sayan Mullick Chowdhury, Jason T. Romancik, Rahul S Bhansali, Elyse I. Harris, Mckenzie Sorrell, Rebecca Masel, Adam S Kittai, Nathan Denlinger, Audrey M Sigmund, Lindsey A. Fitzgerald, Carlos Galvez, Shuo Ma, Jane N Winter, Barbara Pro, Leo I Gordon, Alexey V Danilov, Deborah M. Stephens, Nirav N Shah, Vaishalee P Kenkre, Stefan K Barta, Pallawi Torka, Geoffrey Shouse, Reem Karmali
Publikováno v:
Blood Advances.
Most patients receiving CAR T-cell therapy (CAR-T) for aggressive B-cell lymphoma (B-NHL) will not experience a durable remission. There are several novel agents approved for the treatment relapsed, refractory aggressive B-NHL; however, it remains un